http://purl.org/np/RAsJA-5zi6... RAsJA-5zi6

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

0000-0002-7641-6446

2021-08-24T16:18:41.079Z

http://purl.org/np/RAsJA-5zi6... RAsJA-5zi6

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

There are no FDA or manufacturer guidelines for use of clozapine in pediatric population. Clozapine has been used in the treatment of refractory schizophrenia in child and adolescents. It is estimated that 40%–50% of patients with very early-onset schizophrenia (VEOS) are nonresponders to first-line neuroleptics and that clozapine is likely to be beneficial.

0000-0002-7641-6446

2021-08-24T16:18:41.079Z

http://purl.org/np/RAsJA-5zi6... RAsJA-5zi6

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/MONDO_0005414 MONDO_0005414

0000-0002-7641-6446

2021-08-24T16:18:41.079Z

http://purl.org/np/RAsJA-5zi6... RAsJA-5zi6

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

0000-0002-7641-6446

2021-08-24T16:18:41.079Z

http://purl.org/np/RAsJA-5zi6... RAsJA-5zi6

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/DRUGBANK:DB00363 DRUGBANK:DB00363

0000-0002-7641-6446

2021-08-24T16:18:41.079Z

http://purl.org/np/RAsJA-5zi6... RAsJA-5zi6

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/has_population_context has_population_context

http://purl.org/np/RAsJA-5zi6...#context context

0000-0002-7641-6446

2021-08-24T16:18:41.079Z

http://purl.org/np/RAsJA-5zi6... RAsJA-5zi6

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://pubmed.ncbi.nlm.nih.gov/31082865 pubmed.ncbi.nlm.nih.gov/31082865

0000-0002-7641-6446

2021-08-24T16:18:41.079Z

http://purl.org/np/RAsJA-5zi6... RAsJA-5zi6

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

0000-0002-7641-6446

2021-08-24T16:18:41.079Z

http://purl.org/np/RAsJA-5zi6... RAsJA-5zi6

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/OffLabelIndication OffLabelIndication

0000-0002-7641-6446

2021-08-24T16:18:41.079Z